Reducing Pharmaceutical Prices Requires Competition, Not Price-Fixing
Cutting the red tape around biosimilars is one way that the administration can protect U.S. drug innovation and make medicine more affordable for Americans.
Originally published by nationalreview.com. Syndicated material does not necessarily reflect the views of Grazia British.
More Culture
Don’t Pull Out of Germany
Merz’s stupidity is no excuse for a stupid response. Source link
Step inside the gorgeous, futuristic offices of Vast, the startup designing the next-gen space station
A tall baobab tree greets people inside the Long Beach, California, headquarters of Vast, an aerospace company that is building the space station of the future. It’s planted beneath a…
5 ways high-performing teams stay calm when everything’s on fire
When markets swing, plans break, inboxes explode, and everyone starts saying the situation is “unprecedented” again, most teams do what humans have always done under pressure: they grip…
Confused Trump Openly Admits Plot to Rig Midterms as Polls Turn Brutal
Last week, the Supreme Court gutted protections against racial gerrymandering, and Donald Trump is already urging Republicans to seize on it. Trump unleashed a Truth Social rant on Monday…